The human Cdc25A phosphatase plays a pivotal role at the G1/S transition by activating cyclinE and A/Cdk2 complexes through dephosphorylation. In response to ionizing radiation (IR),
Introduction
Progression through the eukaryotic cell cycle involves the periodic activation of cyclindependent kinases (Cdk). The activities of these enzymes are regulated by multiple mechanisms including binding to their activating proteins, the cyclins. Another layer of control derives from inhibitory phosphorylations of the Cdk and binding of inhibitor proteins but also both activating and inactivating phosphorylations (1) . Cell cycle checkpoints responding to damaged or unreplicated DNA elicit signalling pathways that lead to inhibition of Cdks. At each checkpoint, the cell determines whether it is ready for progression to the next phase and halts progression if conditions are unfavorable; for example if DNA damage has not been repaired (2) . Therefore, the survival of organisms depends on the accurate checkpoint regulation.
The mammalian DNA damage response pathway consists of several families of conserved protein kinases. These include a phosphatidylinositol 3-kinase family member ATM ( a taxia t elangiectasia m utated) and the related kinase ATR (the AT M-and Rad53-r elated protein kinase). These kinases are sensitive to two different types of checkpoint signals. While cells lacking ATM are hypersensitive to ionizing radiation, IR, but not hydroxyurea (HU) or UV, overexpression of a kinase-inactive form of ATR is sensitive to both HU and UV as well as to IR. Downstream of ATM and ATR are two protein kinases, Chk1 and Chk2 (or Cds1). ATR functions as a direct upstream activator of Chk1 in human cells (3) . Both checkpoint kinases directly target regulators of the cell cycle. The final gatekeeper that blocks entry of DNAdamaged cells into mitosis is the G2 checkpoint. The current model posits that DNA damage leads to the activation of Chk1 and Chk2, which in turn phosphorylate S216 on Cdc25C and 4 Cdc25A, the tyrosine phosphatase that activates Cdk2/cyclin A or E complexes needed for DNA synthesis (7) (8) (9) . Thus, in addition to binding of CIP/KIP inhibitors before the G1/S phase transition, phosphorylation of Cdk2 is used to accumulate and maintain cyclin E/Cdk2 complexes in a pre-active stage.
The phosphorylation of Cdc25A by Chk1 induced by UV-irradiation leads to a proteasome-dependent degradation of the protein (10) . In addition, it has been shown that Cdc25A phosphatase is a target of the DNA replication checkpoint (11) . Ionizing radiation also induces degradation of Cdc25A and requires both ATM and the Chk2-mediated phosphorylation of Cdc25A on S123. Mutant Chk2 alleles associated with a variant form of Li-Fraumeni syndrome (12) failed to bind and/or phosphorylate Cdc25A. Recently, it has also been shown that S123 is a target of Chk1 kinase in response to ionizing radiation (13). During the early embryonic cell cycle Chk1 but not Chk2 is activated transiently at the mid-blastula transition and is essential for the cell cycle elongation and Cdc25A degradation at this transition (14).
Here we have performed a detailed molecular analysis of the regulation of Cdc25A by the checkpoint kinase Chk1 in human cells. We show that S75 is a target of Chk1 kinase both in vitro and in vivo. Our data demonstrate that phosphorylation on S75 by Chk1 is required for degradation of Cdc25A in response to UV-induced DNA damage. Phosphorylation of Cdc25A on S123, however leads to degradation of Cdc25A similar to the wild-type protein. These data suggest that phosphorylation of S75 by Chk1 is necessary for the degradation of Cdc25A in response to UV-induced DNA damage while phosphorylation of S123 leads to destruction of Cdc25A in response to ionizing radiation.
Experimental procedures Cell Culture, antibodies and Western Blotting
HeLa and U2OS cells were cultured in Dulbecco´s modified Eagle´s medium (Sigma) supplemented with 10% fetal calf serum (Biochrom) and 2 mM L-glutamine (Sigma) at 37°C with 5% CO 2 in a humidified chamber.
The following antibodies were used: HE 111 for Cyclin E immunoprecipitation, HE 12 for cyclin E western blotting, anti-Cdc25A F6, all from Santa Cruz Biotechnology for Western blotting and C2 for immunoprecipitation of Cdc25A (8) mM NaCl, 0.1% Triton X-100, 5 mM EDTA, 50 mM NaF) supplemented with protease inhibitors (Aprotinin, Leupeptin, Soybean trypsin inhibitor, TPCK, TLCK, PMSF) and 0.1 mM Na 3 VO 4 for 30 minutes on ice followed by centrifugation at 13000 rpm for 10 min. Cleared lysates were assayed for protein concentration using the Bio-Rad protein assay system and subjected to immunoblotting. Bound primary antibodies were detected with either horseradish peroxidase (HRP)-goat anti-rabbit antibody or (HRP)-goat anti-mouse antibody (Jackson).
Enhanced chemiluminescence Western blotting detection reagents were purchased from PerkinElmer Life Sciences.
Cdc25A phosphatase and Histone H1 kinase assays
To prepare the substrate for a Cdc25A phosphatase assay, cyclin B1/Cdk1 was immunoprecipitated using anti-cyclin B1 antibodies from HeLa cells S3 that were arrested in Sphase by treatment with 10 mM hydroxyurea for 18 hours. Under these conditions, Cdk1 Transfections were carried out by using the calcium phosphate method. For transfections 1x10 6 HeLa or U2OS cells were plated per 10 cm dish and allowed to grow for 24h. Plasmid DNA was mixed with CaCl 2 and this mixture was added to a 2x HBS (280 mM NaCl, 1.5 mM on ProteinG-sepharose (Amersham) overnight. The PAA was performed as described (16) .
2D Phosphopeptide Mapping
Two-dimensional phosphopeptide mapping was performed as described (3) . Briefly, U2OS
cells transfected with pX-HA-Cdc25A wt or S75A mutant were metabolically labelled with [ 32 P]-orthophosphate (NEN, 1 mCi/ml) for 1h in presence of 25 µg/ml LLnL (Sigma) to prevent Cdc25A degradation following the subsequent UV-irradiation at 100 J/m 2 . Cells were then exposed to 100 J/m
Results

Analysis of Chk1 and Chk2 phosphorylation sites in Cdc25A
To analyze Cdc25A phosphorylation by the "checkpoint kinases" Chk1 and Chk2 we first performed in vitro kinase assays. GST-Chk1 and GST-Chk2 were purified from insect cells and used to phosphorylate recombinant His 6 -Cdc25A in the presence of [ 32 P] γ−ATP. We found that recombinant GST-Chk1 and GST-Chk2 kinases phosphorylated His 6 -Cdc25A efficiently in vitro (Fig. 1A, lanes 1 and 3) . In contrast the kinase inactive GST-Chk1kin -and phosphorylation of Cdc25A with Chk1 would alter its phosphatase activity, GST-Cdc25A was first phosphorylated by GST-Chk1 or GST-Chk1kin -in the presence of ATP, then immunoprecipitated using antibodies specific for Cdc25A (C2) and analyzed for its ability to dephosphorylate tyrosine phosphorylated cyclin B1/Cdk1. The activity of cyclin B1/Cdk1 was assayed as described previously (8) . Our results show that Cdc25A phosphatase activity decreases about 3-fold in vitro upon phosphorylation by Chk1 kinase (Fig. 1C) . Thus Cdc25A phosphatase activity can be directly inhibited through phosphorylation by Chk1, a process that might occur prior to protein degradation.
Cdc25A is phosphorylated on Ser75 in response to UV-induced DNA damage
The complexity of Chk1 phosphorylation of Cdc25A as demonstrated by two-dimensional phosphopeptide maps reveals that Chk1 phosphorylates Cdc25A at multiple sites (13). In addition to the identification of S123 as a target for Chk1 phosphorylation the human Cdc25A protein sequence contains additional six serine residues that corresponds to the consensus Chk1 and Chk2 phosphorylation motif (Arg-X-X-Ser) (17) . Among them are S75, S123 and S177
( Fig. 2A) . To analyze if these amino acids are phosphorylated by Chk1 in vitro, we prepared his-tagged fragments derived from the regulatory domain of Cdc25A wild-type and with S75A, S123A and S177A mutations and subjected them to phosphorylation by GST-Chk1. Fig. 2B shows that the phosphorylation of Cdc25A fragments is markedly decreased in the case of S123A and S177A mutants compared to the wild-type Cdc25A protein fragments. In the Cdc25A 1-86 fragment where serine 75 is replaced by alanine, phosphorylation is completely abolished. These results suggest that in vitro Cdc25A undergoes phosphorylation by Chk1 on all three sites, namely S75, S123 and S177.
To identify serine residues that are phosphorylated in vivo by Chk1 we performed 2D
phosphopeptide mapping of Cdc25A phosphorylated by Chk1. One candidate serine residue is serine 75. Therefore, His 6 -Cdc25A wild-type or the His 6 -Cdc25A S75A mutant were phosphorylated by GST-Chk1, digested first with trypsin followed by chymotrypsin.
Comparison of phosphopeptide maps prepared from these samples showed that the two predominant phosphopeptides marked with arrows are missing from the map of the phosphorylation sites. U2OS cells were transfected with either HA-tagged Cdc25A wild-type or the mutant proteins S75A, S123A or S177A and irradiated by UV light or not. While the mutant proteins S123A and S177A were rapidly degraded similar to wild-type Cdc25A only the S75A mutant was stable (Fig. 4A) . To demonstrate that the stabilization is not cell type specific we also performed a similar experiment in HeLa cells. Also in this cell line the S75A mutant was resistant in response to UV-irradiation. To exclude that the stabilization of the Cdc25A S75A mutant is not due to de novo protein synthesis, cells were treated after transfection of the different constructs into U2OS cells with the protein synthesis inhibitor cycloheximide, CHX, in a time course and followed up to 90 min (Fig. 4B) . Immunoblotting with anti-HA antibodies shows that both Cdc25A wt and the Cdc25A S123A were rapidly degraded while the Cdc25A S75A mutant was remarkably stable. Thus the stabilization of the Cdc25A S75A mutant is not dependent on new protein synthesis. These results suggests that Ser75 plays an important role in the regulation of Cdc25A stability in response to UV-induced DNA damage. Thus phosphorylation at S75 may represent a critical step towards initiation of checkpoint response to UV-irradiation.
Effect of Cdc25A degradation on cyclin E/Cdk2 kinase activity
It has previously been shown that UV-induced degradation of Cdc25A also declines the kinase activity of its downstream target cyclin E/Cdk2 (10). We therefore wished to determine if stabilization of Cdc25A by mutation of serine-75 to alanine also leads to a stabilization of cyclin E/Cdk2 activity. U2OS cells were transfected with either vector alone (mock), HA-Cdc25A
wild-type or HA-Cdc25A S75A, respectively. Similarily to Mailand et al., 2000, we observed that Cdc25A wild-type proteins and its associated phosphatase activity (not shown) declined within 30 min after exposure to UV. The S75A mutant however, remained stable. The endogenous levels of Chk1 protein were equal in the presence of either HA-Cdc25A wt or HACdc25A S75A. The slower migrating form of Chk1 observed in response to UV-treatment is induced by phosphorylation of Chk1 on S345 (5) (6). We further found that activation of the Cdc25A downstream target cyclin E/Cdk2 was inhibited in the presence of HA-Cdc25A wildtype in response to UV-induced DNA damage (Fig. 5A) . This inhibition would then lead to a block of entry into S-phase in response to checkpoint activation. The presence of HA-Cdc25A
Discussion
In this study, we have analyzed the regulation of the human Cdc25A phosphatase in reponse to UV-induced DNA damage. We report that Cdc25A is phosphorylated on serine 75 following irradiation of cells with UV-light which in turn leads to its degradation. Furthermore, we show that S75 is phosphorylated both in vivo and in vitro by Chk1. It has been reported previously that Cdc25A is phosphorylated on serine 123 by Chk2 kinase in response to ionizing radiation (IR) (18) . This phosphorylation induces a rapid proteasome-dependent degradation of Cdc25A and subsequent silencing of cyclin E/Cdk2 kinase activity. Interestingly, Cdc25A can also be phosphorylated by Chk1 kinase on serine 123 in vitro and in vivo (13). Thus, it seems that Chk1 is also a target for the IR-induced S-phase checkpoint. Our findings support a role of Chk1 in the regulation of Cdc25A in the UV-induced DNA damage checkpoint. The work presented herein shows that Cdc25A is phosphorylated by Chk1 at a different serine residue, namely serine 75. S75 is also phosphorylated in vivo in cells exposed to UV. Although Chk1 is able to phosphorylate Cdc25A on S123, this site does not seem to be relevant in response to UV-induced DNA damage.
Our experiments further demonstrate that in the absence of UV-damage but in the presence of the protein synthesis inhibitor cycloheximide both wild-type Cdc25A and the Cdc25A S123A mutant are rapidly degraded while the Cdc25A S75A mutant was notably stable (Fig. 4B ).
Taking into account that the protein levels of Cdc25A are regulated during the cell cycle with a continuous increase in abundance from late G1 until mitosis followed by degradation at mitotic exit (19) (20), our results suggest that S75 rather than S123 may represent the main signal for rapid destruction of the protein during interphase in an unperturbed cell cycle. The presence of SCF components in Cdc25A immunoprecipitates indicates that phosphorylation on S75 may provide the signal for recuiting F-box protein to the complex (20) .
Intriguingly, it has also been shown that Chk1 is essential for Cdc25A phosphorylation and degradation of the phosphatase at the midblastula transition (MBT) in Xenopus embryos (14) which represents the physiological DNA replication checkpoint. Importantly, for its Chk1-induced degradation, Xenopus Cdc25A requires phosphorylation at serine 73, a site that corresponds to serine 75 in human Cdc25A. Although Chk1 is able to phosphorylate Xenopus data, however, demonstrate that Chk1 is able to directly phosphorylate human Cdc25A at S75 in vitro and that the same site is phosphorylated in vivo in response to UV-induced DNA damage. It would therefore be intriguing to investigate if the DNA replication checkpoint in human cells will be regulated via S75 phosphorylation of Cdc25A.
Our findings suggest the following model for the S-phase checkpoint: In response to UVinduced DNA damage ATR is activated which in turn activates Chk1. Chk1 then would phosphorylate Cdc25A on S75, which may first lead to an inactivation of Cdc25A phosphatase activity (Fig. 1C) followed by a degradation of the phosphatase, and in turn, the failure to maintain activation of Cyclin/Cdk2 complexes and a resultant inhibition of DNA synthesis (Fig.   6 ). In contrast, ionizing radiation IR, leads via activation of ATM and Chk2 to a Chk2-dependent phosphorylation of Cdc25A on S123, a process that can be catalyzed either by Chk1 or Chk2 kinases. Phosphorylation of Cdc25A on a different serine residue, S123, promotes its rapid destruction in response to IR-induced DNA damage. Thus, human cells express at least two mechanisms in response to DNA damage that signal via differential phosphorylations of Cdc25A leading to a block of S-phase entry. S75A and HA-Cdc25A S123A, respectively. Cycloheximide (CHX) was added for the times indicated. Cdc25A protein levels were determined as indicated in (A). UV-irr.
